A comparison of the effectiveness of cationic polymers poly-l-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC)

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 65, Issue 3, 2007, Pages 388-397

  Farrell, Laura Lee ^a   Pepin, Joel ^a   Kucharski, Cezary ^a   Lin, Xiaoyue ^a   Xu, Zhenghe ^a   Uludag, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bone marrow stromal cells; Cationic polymers; DNA binding; DNA uptake; Flow cytometry; Non viral gene delivery

Indexed keywords

CATION; ENHANCED GREEN FLUORESCENT PROTEIN; PLASMID DNA; POLYETHYLENEIMINE; POLYLYSINE; POLYMER;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL NUCLEUS; DNA BINDING; DRUG UPTAKE; EVALUATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; INTERNALIZATION; NONHUMAN; NONVIRAL GENE THERAPY; PHENOTYPE; PLASMID; POLYMERIZATION; RAT; SPRAGUE DAWLEY RAT; STROMA CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BONE MARROW CELLS; CATIONS; CELL NUCLEUS; CELLS, CULTURED; ENDOCYTOSIS; ENDOSOMES; FEMALE; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; PLASMIDS; POLYETHYLENEIMINE; POLYLYSINE; RATS; RATS, SPRAGUE-DAWLEY; STROMAL CELLS; TRANSFECTION;

EID: 33847309821     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.11.026     Document Type: Article

References (38)

1. Van Damme A., Vanden Driessche T., Collen D., and Chuah M.K. Bone marrow stromal cells as targets for gene therapy. Curr. Gene Ther. 2 (2002) 195-209
2. Krebsbach P.H., Zhang K., Malik A.K., and Kurachi K. Bone marrow stromal cells as a genetic platform for systematic delivery of therapeutic proteins in vivo: human factor IX model. J. Gene Med. 5 (2003) 11-17
3. Takagi M. Cell processing engineering for ex-vivo expansion of hematopoietic cells. J. Biosci. Bioeng. 99 (2005) 189-196
4. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow-derived stem cells. Blood 102 (2003) 3483-3493
5. Zimmet J.M., and Hare J.M. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res. Cardiol. 100 (2005) 471-481
6. Eliopoulos N., Al-Khaldi A., Beausejour C.M., Momparler R.L., Momparler L.F., and Galipeau J. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Gene Ther. 9 (2002) 452-462
7. Schwarz E.J., Reger R.L., Alexander G.M., Class R., Azizi S.A., and Prockop D.J. Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther. 8 (2001) 1214-1223
8. Kume A., Hashiyama M., Suda T., and Ozawa K. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. Stem Cells 17 (1999) 226-232
9. Relander T., Fahlman C., Karlsson S., and Richter J. Low level of gene transfer to and engraftment of murine bone marrow cells from long-term bone marrow cultures. Exp. Hematol. 28 (2000) 373-381
10. Pawliuk R., Bachelot T., Raftopoulos H., Kalberer C., Humphries R.K., Bank A., and Leboulch P. Retroviral vectors aimed at the gene therapy of human beta-globin gene disorders. Ann. N.Y. Acad. Sci. 850 (1998) 151-162
11. Marx J.C., Allay J.A., Persons D.A., Nooner S.A., Hargrove P.W., Kelly P.F., Vanin E.F., and Horwitz E.M. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Hum. Gene Ther. 10 (1999) 1163-1173
12. Mosca J.D., Hendricks J.K., Buyaner D., Davis-Sproul J., Chuang L.C., Majumdar M.K., Chopra R., Barry F., Murphy M., Thiede M.A., Junker U., Rigg R.J., Forestell S.P., Bohnlein E., Storb R., and Sandmaier B.M. Mesenchymal stem cells as vehicles for gene delivery. Clin. Orthop. Relat. Res. S379 (2000) S71-S90
13. Kurre P., Anandakumar P., and Kiem H.P. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Gene Ther. 13 (2006) 369-373
14. Deng Y., Guo X., Yuan Q., and Li S. Efficiency of adenoviral vector mediated CTLA4Ig gene delivery into mesenchymal stem cells. Chin. Med. J. (Engl.) 116 (2003) 1649-1654
15. Clements B.A., Bai J., Kucharski C., Farrell L.L., Lavasanifar A., Ritchie B., Ghahary A., and Uludag H. RGD conjugation to polyethylenimine does not improve DNA delivery to bone marrow stromal cells. Biomacromolecules 7 (2006) 1481-1488
16. Lakshmipathy U., Pelacho B., Sudo K., Linehan J.L., Coucouvanis E., Kaufman D.S., and Verfaillie C.M. Efficient transfection of embryonic and adult stem cells. Stem Cells 22 (2004) 531-543
17. Kim S.W., Ogawa T., Tabata Y., and Nishimura I. Efficacy and cytotoxicity of cationic-agent-mediated nonviral gene transfer into osteoblasts. J. Biomed. Mat. Res. 71 (2004) 308-315
18. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92 (1995) 7297-7301
19. Wu G.Y., and Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262 (1987) 4429-4432 Erratum in: J. Biol. Chem. 262 (1988) 588
20. Varkey M., Kucharski C., Haque T., Sebald W., and Uludag H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin. Orthop. Rel. Res. 443 (2006) 113-123
21. Haque T., Uludag H., Zernicke R.F., Winn S.R., and Sebald W. Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein-2 treatment in vitro. Tissue Eng. 11 (2005) 634-644
22. Bai J., Acan B., Ghahary A., Ritchie B., Somayaji V., and Uludag H. Polyethyleneimine/arginine-glycine-aspartic Acid conjugates prepared by N-succinimidyl 3-(2-pyridyldithio)propionate: an investigation of peptide coupling and conjugate stability. J. Polym. Sci. Polym. Chem. 42 (2004) 6143-6156
23. Grosse S., Aron Y., Thevenot G., Francois D., Monsigny M., and Fajac I. Potocytosis and cellular exit of complexes as cellular pathways for gene delivery by polycations. J. Gene Med. 7 (2005) 1275-1286
24. Twaites B.R., De Las Heras Alarcon C., Cunliffe D., Lavigne M., Pennadam S., Smith J.R., Gorecki D.C., and Alexander C. Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J. Control. Rel. 97 (2004) 551-566
25. Petersen H., Kunath K., Martin A.L., Stolnik S., Roberts C.J., Davies M.C., and Kissel T. Star-shaped poly(ethylene glycol)-block-polyethlenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3 (2002) 926-936
26. Okuda T., Kidoki S., Ohsaki M., Koyama Y., Yoshikawa K., Niidome T., and Aoyagi H. Time-dependent complex formation of dendritic poly(l-lysine) with plasmid DNA correlation with in vitro transfection efficiencies. Org. Biomol. Chem. 1 (2003) 1270-1273
27. Chan C.-K., Senden T., and Jans D.A. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther. 7 (2000) 1690-1697
28. Miyata K., Kakizawa Y., Nishiyama N., Harada A., Yamasaki Y., Koyama H., and Kataoka K. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J. Am. Chem. Soc. 126 (2004) 2355-2361
29. Bremner K.H., Seymour L.W., Logan A., and Read M.L. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconj. Chem. 15 (2004) 152-161
30. Clamme J.P., Krishnamoorthy G., and Mely Y. Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy. Biochim. Biophy. Acta - Biomembr. 1617 (2003) 52-61
31. Godbey W.T., Wu K.K., and Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Nat. Acad. Sci. USA 96 (1999) 5177-5181
32. Talsma S.S., Babensee J.E., Murthy N., and Williams I.R. Development and in vitro validation of a targeted delivery vehicle for DNA vaccines. J. Control. Rel. 112 (2006) 271-279
33. Grosse S., Aron Y., Honore I., Thevenot G., Danel C., Roche A.C., Monsigny M., and Fajac I. Lactosylated polyethylenimine for gene transfer into airway epithelial cells: role of the sugar moiety in cell delivery and intracellular trafficking of the complexes. J. Gene Med. 6 (2004) 345-356
34. Ndoye A., Merlin J.L., Leroux A., Dolivet G., Erbacher P., Behr J.P., Berg K., and Guillemin F. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes. J. Gene Med. 6 (2004) 884-894
35. Funhoff A.M., van Nostrum C.F., Koning G.A., Schuurmans-Nieuwenbroek N.M., Crommelin D.J., and Hennink W.E. Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules 5 (2004) 32-39
36. Park J., Ries J., Gelse K., Kloss F., von der Mark K., Wiltfang J., Neukam F.W., and Schneider H. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 10 (2003) 1089-1098
37. Pochampally R.R., Horwitz E.M., DiGirolamo C.M., Stokes D.S., and Prockop D.J. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Gene Ther. 12 (2005) 1119-1125
38. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., and Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24 (2003) 1121-1131